Barboza MA

Language: Spanish
References: 16
Page: 37-43
PDF size: 113.84 Kb.

ABSTRACT

Epidemiologic situation related to severe acute respiratory syndrome Coronavirus 2 (SARSCoV- 2) pandemic, has lead to protocol modifications in terms of management and therapeutic approaches for many medical conditions, also in administrative, infrastructure and human resources in health care services worldwide. In this context, attention of neurological emergencies also faces a modification in their pathway, in terms of a special care for patient's and medical staff protection, such as acute stroke (ischemic or hemorrhagic), acute polyneuropathy, multiple sclerosis acute relapse, acute myasthenic crisis, meningo-encephalitis and status epilepticus, among others.
Local protocols for attention and protection of neurology medical personnel, which is involved in evaluation of patients during this epidemiological outbreak, allow to keep offering a modified but evidence-based quality care.

REFERENCES

1. Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. NEJM 2020 February 28; epub ahead of print, doi: 10.1056/NEJMoa2002032

2. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506.

3. Majersik J, Reddy V. Acute neurology during the COVID-19 pandemic: supporting the frontline. Neurology 2020, epub ahead of print, DOI:10.1212/WLN.0000000000009564.

4. Mao L, Wang M, Chen S, et al. Neurological Manifestations of hospitalized patients with COVID- 19 in Wuhan, China: a retrospective case series study. MedRxiv 2020; epub ahead of print; doi.org/10.1101/2020.02.22.20026500.

5. Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with Coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020; epub ahead of print. DOI: 10.1001/jamaneurol.2020.1127.

6. MInisterio de Salud de Costa Rica. Lineamientos Nacionales para la vigilancia de la enfermedad COVID-19. Versión nº11, 02 de abril de 2020. Consultado el 10 de abrile en: https://www.ministeriodesalud.go.cr/index.php/centr o-de-prensa/noticias/741-noticias-2020/1532- lineamientosnacionales-para-la-vigilancia-de-lainfeccion- por-coronavirus-2019-ncov.

7. Khrosravani H, Rajendram P, Notario L, et al. Protected code stroke: hyperacute stroke management duringa the Coronavirus disease 2019. Stroke 2020, epub ahead of print, DOI:10.1161/STROKEAHA.120.029838.

8. Lyden P. Temporary emergency guidance to US Stroke centers during the COVID-19 pandemic: on behalf of AHA/ASA stroke council leadership. Stroke 2020, epub ahead of print, DOI:20- 1161/STROKEAHA.120.030023.

9. Baracchini C, Pieroni A, Viaro F, et al. Acute stroke management pathway during Coronavirus-19 pandemic. Neurol Sci 2020, epub ahead of print, DOI:10.1007/s10072-020-04375-9.

10. Zhao H, Shen E, Zhou H, Liu J, et al. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence. Lancet Neurol 2020, epub ahead of print, DOI:10.1016/S1474-4422(20)30109- 5

11. Desforges M, Le Coupanec A, Dubeau P, et al. Human Coronaviruses and other respiratory viruses: understimated opportunistic pathogens of the central nervous system?. Viruses 2019;12(1). doi: 10.3390/v12010014.

12. Filatov A, Sharma P, Hindi F, et al. Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy. Cureus 2020;12(3): e7352. doi:10.7759/cureus.7352

13. Ministerio de Salud de Costa Rica. Protocolo para la vigilancia y atención de las encefalitis y meningoencefalitis virales (VNO, EEE, EEV, EEO). San José, Costa Rica. Primera Edición, 2015

14. Tunkel AR, Glaser CA, Bloch KC, et al. The Management of Encephalitis: Clinical Practice Guidelines by the Infectious Diseases Society of America. Clin Infec Diseases 2008; 47:303-327.

15. Gaieski DF, Nathan BR, O’Brien NF. Emergency neurologic life support: meningitis and encephalitis. Neurocrit Care 2015;23 Suppl 2:S110-8.

16. Association of British Neurologists. ABN guidance on COVID-19 for people with neurological conditions, their doctors and carers. ABN executive, version 3 22 march 2020. Consultado el 10 de abril de 2020 en https://www.theabn.org/page/abnguidelines